“Intravesical BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer During COVID-19 Pandemic: Mutual Impact and Implications”. 2022. Chemical Biology Letters 9 (2): 267. https://pubs.thesciencein.org/journal/index.php/cbl/article/view/267.